viking therapeutics stock forecast 2022
Ad Five Under-The-Radar Investments You Cant Afford to Miss. Viking Therapeutics Stock Forecast VKTX stock price prediction.
Best Penny Stocks To Watch This Coming Week
VKTX stock quote history news and other vital information to help you with your stock trading and investing.
. Find the latest Viking Therapeutics Inc. Olson forecasts that the biotechnology company will post earnings per share of 020 for the. Viking Therapeutics Inc.
Viking Therapeutics Inc. Viking Therapeutics Inc. Their forecasts range from 1000 to 2100.
NASDAQ Updated Feb 25 2022 1152 PM. 2022 Search Stock FX pair Crypto or Commodity. And has now fallen 3 days in a row.
The Technical Analyst. Given Viking Therapeutics stronger consensus rating and higher probable upside analysts plainly believe Viking Therapeutics is more favorable than Amphastar Pharmaceuticals. On average they expect Viking Therapeutics stock price to reach 1550 in the next twelve months.
NASDAQVKTX Equities research analysts at Oppenheimer issued their Q1 2022 earnings estimates for Viking Therapeutics in a note. The best long-term short-term Viking Therapeutics share price prognosis for 2022 2023 2024 2025. VKTX a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders announced today that the company will release financial results for the fourth quarter and year-end 2021 after the market close on.
Viking Therapeutics Inc NASDAQVKTX stock. 2 weeks VIKING THERAPEUTICS INC share price prediction for. The Viking Therapeutics stock price fell by -393 on the last day Friday 11th Mar 2022 from 331 to 318.
William Blair analyst A. Actively observing the price movement in the last trading the stock closed the session at 331 falling within a range of 318 and 338. Viking Therapeutics Inc Stock Forecast and Price Prognosis Data for 2022.
Stock Option Right to Buy 2022-01-04. 2 2022 PRNewswire -- Viking Therapeutics Inc. Updated on Mar 11 2022 Sell candidate since 2022-03-11 PDF.
If you had invested in Viking Therapeutics stock at 896 your return over the last 6 years would have been -6228 for an annualized return of -15 not including any dividends or. VIKING THERAPEUTICS INC stock price forecast for further price development up to 1874 time horizon. Analysts project the companys earnings per share EPS to be -019 which has seen fiscal year 2021 EPS growth forecast to increase to -074 and.
NASDAQVKTX Equities researchers at Oppenheimer issued their Q1 2022 earnings estimates for shares of Viking Therapeutics in a research report issued to clients and investors on Thursday February 10th. NASDAQVKTX shares rose in value on Friday 031122 with the stock price down by -393 to the previous days close as strong demand from buyers drove the stock to 318. The 9 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 2000 with a high estimate of 3000 and a.
This suggests a possible upside of 4150 from the stocks current price. 52 rows Viking Therapeutics has a consensus price target of 1550 suggesting a potential upside of 27260. Check out if it is time to buy or sell.
Viking Therapeutics s earnings in 2022 is -54990000On average 7 Wall Street analysts forecast VKTXs earnings for 2022 to be -67392097 with the lowest VKTX earnings forecast at -77579275 and the highest VKTX earnings forecast at -58772178. This is 233 less than the trading day before Friday 25th Feb 2022. The average Viking Therapeutics stock forecast 2022 represents a 1891 increase from the last price of 350999999046326.
1 day and price target of 393 USD. Biotechnology Stock Price Forecast Insider Ratings Fundamentals Signals. Viking Therapeutics stock downgraded from HoldAccumulate to Sell Candidate after Friday trading session.
SAN DIEGO March 8 2022 PRNewswire -- Viking Therapeutics Inc. Viking Therapeutics Inc. During the day the stock fluctuated 360 from a day low at 333 to a day high of 345.
VKTX VIKING THERAPEUTICS INC. VKTX a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders today announced that the company will present at two upcoming investor conferences. Viking Therapeutics Inc stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.
Hsieh now expects that the biotechnology company will post earnings per share of 018 for the quarter down. Stock Predictons by days. Viking Therapeutics Incs market cap currently stands at around 30610 million with investors looking forward to this quarters earnings report slated for Feb 15 2022 Feb 21 2022.
VKTX 343 000 000 Post-Market 015 437 17648. Viking Therapeutics Stock Price Quote NASDAQ. Five Stocks That Will Define The Next Decade of Retirement.
7 Wall Street analysts have issued 12 month target prices for Viking Therapeutics stock. Monday 28th Feb 2022 VKTX stock ended at 335. For Viking Therapeutics stock forecast for 2022 10 predictions are offered for each month of 2022 with average Viking Therapeutics stock forecast of 417 a high forecast of 516 and a low forecast of 353.
NASDAQVKTX Equities researchers at William Blair lowered their Q1 2022 earnings per share estimates for shares of Viking Therapeutics in a research report issued on Thursday February 10th. 25 Feb 2022 1618 pm. SAN DIEGO Feb.
Stock Price and Discussion Stocktwits. Stock was originally listed at a price of 896 in Apr 29 2015.
Viking Therapeutics Inc Share Price Usd0 00001
Vktx Stock Price And Chart Nasdaq Vktx Tradingview
What You Need To Know About 4d Molecular Therapeutics Inc S Nasdaq Fdmt Investor Composition
Intercept Icpt Q4 Earnings Sales Beat Ocaliva In Focus March 3 2022 Zacks Com
Viking Therapeutics Inc Share Price Usd0 00001
Imfutyzk7 O2mm
3 Biotech Stocks That Could Go Parabolic In 2022 The Motley Fool
Here S Why We Re Not Too Worried About Viking Therapeutics Nasdaq Vktx Cash Burn Situation Nasdaq
Cara Therapeutics Nasdaq Cara Investors Are Sitting On A Loss Of 48 If They Invested A Year Ago
How Much Upside Is Left In Viking Therapeutics Inc Vktx Wall Street Analysts Think 204 Nasdaq
Viking Therapeutics Inc Vktx Now Trades Above Golden Cross Time To Buy Nasdaq
Viking Therapeutics Inc Shares Close In On 52 Week Low Market Mover Nasdaq
Kaiser Research Online Kaiser Blog Kaiser Media Watch Blog Current Thu Mar 17 2022
Viking Therapeutics Nasdaqcm Vktx Share Price News Analysis Simply Wall St
Viking Therapeutics To Report Financial Results For Fourth Quarter And Year End 2021 On February 9 2022
Vktx Viking Therapeutics Inc Cnnmoney Com
3 Strong Buy Stocks Under 10 That Are Poised To Take Off Nasdaq
What Type Of Shareholders Own The Most Number Of Viking Therapeutics Inc Nasdaq Vktx Shares
Vktx Stock Price And Chart Nasdaq Vktx Tradingview